Annual EBITDA
-$6.89 M
+$3.97 M+36.57%
December 31, 2023
Summary
- As of February 7, 2025, ADIL annual EBITDA is -$6.89 million, with the most recent change of +$3.97 million (+36.57%) on December 31, 2023.
- During the last 3 years, ADIL annual EBITDA has risen by +$4.04 million (+36.97%).
- ADIL annual EBITDA is now -1579.85% below its all-time high of -$410.00 thousand, reached on December 31, 2016.
Performance
ADIL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.21 M
+$75.80 K+3.31%
September 30, 2024
Summary
- As of February 7, 2025, ADIL quarterly EBITDA is -$2.21 million, with the most recent change of +$75.80 thousand (+3.31%) on September 30, 2024.
- Over the past year, ADIL quarterly EBITDA has dropped by -$366.40 thousand (-19.86%).
- ADIL quarterly EBITDA is now -2430.09% below its all-time high of -$87.40 thousand, reached on December 31, 2016.
Performance
ADIL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$8.13 M
-$853.50 K-11.73%
September 30, 2024
Summary
- As of February 7, 2025, ADIL TTM EBITDA is -$8.13 million, with the most recent change of -$853.50 thousand (-11.73%) on September 30, 2024.
- Over the past year, ADIL TTM EBITDA has dropped by -$1.66 million (-25.73%).
- ADIL TTM EBITDA is now -8392.16% below its all-time high of -$95.70 thousand, reached on June 30, 2016.
Performance
ADIL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ADIL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.6% | -19.9% | -25.7% |
| 3 y3 years | +37.0% | -19.9% | -25.7% |
| 5 y5 years | +34.2% | -19.9% | -25.7% |
ADIL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.1% | -62.9% | +49.9% | -25.7% | +54.0% |
| 5 y | 5-year | at high | +61.1% | -62.9% | +54.2% | -25.7% | +54.0% |
| alltime | all time | -1579.8% | +61.1% | -2430.1% | +69.8% | -8392.2% | +54.0% |
Adial Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.21 M(-3.3%) | -$8.13 M(+11.7%) |
| Jun 2024 | - | -$2.29 M(+24.0%) | -$7.27 M(+12.5%) |
| Mar 2024 | - | -$1.84 M(+3.4%) | -$6.46 M(-6.2%) |
| Dec 2023 | -$6.89 M(-36.6%) | -$1.78 M(+31.4%) | -$6.89 M(-10.6%) |
| Sep 2023 | - | -$1.36 M(-8.1%) | -$7.70 M(-13.4%) |
| Jun 2023 | - | -$1.48 M(-34.9%) | -$8.90 M(-16.6%) |
| Mar 2023 | - | -$2.27 M(-12.7%) | -$10.66 M(-6.8%) |
| Dec 2022 | -$10.86 M(-38.6%) | -$2.60 M(+1.7%) | -$11.44 M(-13.7%) |
| Sep 2022 | - | -$2.55 M(-21.2%) | -$13.26 M(-10.1%) |
| Jun 2022 | - | -$3.24 M(+6.6%) | -$14.76 M(-7.2%) |
| Mar 2022 | - | -$3.04 M(-31.1%) | -$15.90 M(-10.1%) |
| Dec 2021 | -$17.69 M(+61.8%) | -$4.42 M(+9.0%) | -$17.69 M(+5.7%) |
| Sep 2021 | - | -$4.05 M(-7.7%) | -$16.74 M(+4.4%) |
| Jun 2021 | - | -$4.39 M(-9.1%) | -$16.03 M(+19.1%) |
| Mar 2021 | - | -$4.83 M(+39.1%) | -$13.46 M(+23.1%) |
| Dec 2020 | -$10.93 M | -$3.47 M(+4.0%) | -$10.93 M(+14.5%) |
| Sep 2020 | - | -$3.34 M(+83.5%) | -$9.55 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$1.82 M(-20.9%) | -$7.96 M(-4.1%) |
| Mar 2020 | - | -$2.30 M(+10.0%) | -$8.30 M(+0.6%) |
| Dec 2019 | -$8.24 M(-21.2%) | -$2.09 M(+19.8%) | -$8.24 M(+13.9%) |
| Sep 2019 | - | -$1.75 M(-19.1%) | -$7.24 M(-43.5%) |
| Jun 2019 | - | -$2.16 M(-4.0%) | -$12.80 M(+3.4%) |
| Mar 2019 | - | -$2.25 M(+107.7%) | -$12.39 M(+18.4%) |
| Dec 2018 | -$10.46 M(+952.3%) | -$1.08 M(-85.2%) | -$10.46 M(+7.8%) |
| Sep 2018 | - | -$7.31 M(+320.0%) | -$9.70 M(+265.8%) |
| Jun 2018 | - | -$1.74 M(+432.3%) | -$2.65 M(+130.2%) |
| Mar 2018 | - | -$327.10 K(+1.7%) | -$1.15 M(+15.9%) |
| Dec 2017 | -$994.40 K(+142.5%) | -$321.70 K(+22.6%) | -$994.40 K(+30.8%) |
| Sep 2017 | - | -$262.30 K(+8.7%) | -$760.10 K(+26.8%) |
| Jun 2017 | - | -$241.30 K(+42.7%) | -$599.40 K(+32.1%) |
| Mar 2017 | - | -$169.10 K(+93.5%) | -$453.80 K(+59.4%) |
| Dec 2016 | -$410.00 K(-49.8%) | -$87.40 K(-14.0%) | -$284.70 K(+44.3%) |
| Sep 2016 | - | -$101.60 K(+6.2%) | -$197.30 K(+106.2%) |
| Jun 2016 | - | -$95.70 K | -$95.70 K |
| Dec 2015 | -$817.40 K | - | - |
FAQ
- What is Adial Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals annual EBITDA year-on-year change?
- What is Adial Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Adial Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals TTM EBITDA year-on-year change?
What is Adial Pharmaceuticals annual EBITDA?
The current annual EBITDA of ADIL is -$6.89 M
What is the all time high annual EBITDA for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high annual EBITDA is -$410.00 K
What is Adial Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, ADIL annual EBITDA has changed by +$3.97 M (+36.57%)
What is Adial Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of ADIL is -$2.21 M
What is the all time high quarterly EBITDA for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high quarterly EBITDA is -$87.40 K
What is Adial Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, ADIL quarterly EBITDA has changed by -$366.40 K (-19.86%)
What is Adial Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of ADIL is -$8.13 M
What is the all time high TTM EBITDA for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high TTM EBITDA is -$95.70 K
What is Adial Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, ADIL TTM EBITDA has changed by -$1.66 M (-25.73%)